| scholarly article | Q13442814 |
| P356 | DOI | 10.1089/104303403321467180 |
| P953 | full work available at URL | http://www.liebertpub.com/doi/pdf/10.1089/104303403321467180 |
| https://doi.org/10.1089/104303403321467180 | ||
| https://europepmc.org/articles/PMC2581862 | ||
| https://europepmc.org/articles/pmc2581862?pdf=render | ||
| https://europepmc.org/articles/PMC2581862?pdf=render | ||
| P932 | PMC publication ID | 2581862 |
| P698 | PubMed publication ID | 12691607 |
| P5875 | ResearchGate publication ID | 10807409 |
| P50 | author | Alfred I Geller | Q64944560 |
| P2093 | author name string | Wei Zhang | |
| Mei Sun | |||
| Guo-Rong Zhang | |||
| Lingxin Kong | |||
| Xiaodan Wang | |||
| Courtney Holmes | |||
| David S. Goldstein | |||
| P2860 | cites work | Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer | Q31045537 |
| The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system | Q31128775 | ||
| Treatment of Parkinsonism With Levodopa | Q34240368 | ||
| Gene therapy for Parkinson's disease: determining the genes necessary for optimal dopamine replacement in rat models | Q34298405 | ||
| Cell therapy | Q34467385 | ||
| Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease. | Q35734505 | ||
| Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. | Q35870965 | ||
| Genetically modified cells: applications for intracerebral grafting | Q36705238 | ||
| Dopamine cell replacement: Parkinson's disease | Q37916270 | ||
| Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease | Q39519102 | ||
| A tyrosine hydroxylase-neurofilament chimeric promoter enhances long-term expression in rat forebrain neurons from helper virus-free HSV-1 vectors | Q40838016 | ||
| Regulation of dopamine production by genetically modified primary fibroblasts | Q41061107 | ||
| General strategy for constructing large HSV-1 plasmid vectors that co-express multiple genes | Q42113935 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. | Q42815788 | ||
| Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase | Q43185222 | ||
| Significant behavioral recovery in Parkinson's disease model by direct intracerebral gene transfer using continuous injection of a plasmid DNA-liposome complex | Q44553274 | ||
| Developmental potential of quail dorsal root ganglion cells analyzed in vitro and in vivo. | Q44933058 | ||
| HSV-1 vector mediated neuronal gene delivery. Strategies for molecular neuroscience and neurology | Q45111676 | ||
| Fifty-one kilobase HSV-1 plasmid vector can be packaged using a helper virus-free system and supports expression in the rat brain | Q45744857 | ||
| Improved titers for helper virus-free herpes simplex virus type 1 plasmid vectors by optimization of the packaging protocol and addition of noninfectious herpes simplex virus-related particles (previral DNA replication enveloped particles) to the pa | Q45747563 | ||
| Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease. | Q45756120 | ||
| Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase enhance dopamine delivery after L-3, 4-dihydroxyphenylalanine administration in Parkinsonian rats. | Q45857411 | ||
| Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts | Q45877347 | ||
| Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression | Q45881013 | ||
| L-Dopa and dopamine-producing gene cassettes for gene therapy approaches to Parkinson's disease | Q45881504 | ||
| Role of aromatic L-amino acid decarboxylase for dopamine replacement by genetically modified fibroblasts in a rat model of Parkinson's disease. | Q45884094 | ||
| A 6-hydroxydopamine-induced selective parkinsonian rat model | Q46617652 | ||
| Modulation of rat rotational behavior by direct gene transfer of constitutively active protein kinase C into nigrostriatal neurons. | Q48455595 | ||
| An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain | Q48723498 | ||
| Circling behavior in rats with partial, unilateral nigro-striatal lesions: Effect of amphetamine, apomorphine, and DOPA | Q57913305 | ||
| Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease | Q64383353 | ||
| Striatal neurons with aromatic L-amino acid decarboxylase-like immunoreactivity in the rat | Q69683841 | ||
| Behavioral effects and gene delivery in a rat model of Parkinson's disease | Q71967787 | ||
| Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection | Q72522228 | ||
| Estimation of striatal dopamine spillover and metabolism in vivo | Q73144506 | ||
| [Comparison of the immune response to gene transfer into the rat brain with helper or helper virus-free HSV-1 vectors] | Q78948957 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | genetics | Q7162 |
| Parkinson's disease | Q11085 | ||
| vector-borne disease | Q2083837 | ||
| molecular medicine | Q3523816 | ||
| genetic vector | Q427389 | ||
| Herpes simplex virus type 1 | Q655331 | ||
| P304 | page(s) | 415-424 | |
| P577 | publication date | 2003-03-01 | |
| 2003-03-20 | |||
| P1433 | published in | Human Gene Therapy | Q15757580 |
| P1476 | title | Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector | |
| Correction of a Rat Model of Parkinson's Disease by Coexpression of Tyrosine Hydroxylase and Aromatic Amino Acid Decarboxylase from a Helper Virus-Free Herpes Simplex Virus Type 1 Vector | |||
| P478 | volume | 14 |
| Q38669532 | A 16 bp upstream sequence from the rat tyrosine hydroxylase promoter supports long-term expression from a neurofilament promoter, in a helper virus-free HSV-1 vector system |
| Q40305783 | A helper virus-free HSV-1 vector containing the vesicular glutamate transporter-1 promoter supports expression preferentially in VGLUT1-containing glutamatergic neurons |
| Q47300209 | And Then There Was Light: Perspectives of Optogenetics for Deep Brain Stimulation and Neuromodulation |
| Q38532388 | Antibody-mediated targeted gene transfer of helper virus-free HSV-1 vectors to rat neocortical neurons that contain either NMDA receptor 2B or 2A subunits |
| Q39685068 | Antibody-mediated targeted gene transfer to NMDA NR1-containing neurons in rat neocortex by helper virus-free HSV-1 vector particles containing a chimeric HSV-1 glycoprotein C-staphylococcus A protein |
| Q36969314 | Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behaviora |
| Q36969309 | Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease |
| Q33327584 | Enhanced nigrostriatal neuron-specific, long-term expression by using neural-specific promoters in combination with targeted gene transfer by modified helper virus-free HSV-1 vector particles |
| Q55418920 | Gene Therapy for Parkinson's Disease, An Update. |
| Q37796024 | Gene therapy for dopamine replacement. |
| Q35206326 | Gene therapy progress and prospects: Parkinson's disease |
| Q40164850 | Glutamatergic or GABAergic neuron-specific, long-term expression in neocortical neurons from helper virus-free HSV-1 vectors containing the phosphate-activated glutaminase, vesicular glutamate transporter-1, or glutamic acid decarboxylase promoter |
| Q36897379 | HSV-1 amplicon vectors: a promising and versatile tool for gene delivery. |
| Q36288901 | HSV-1-based amplicon vectors: design and applications |
| Q39923388 | Herpes Virus Amplicon Vectors |
| Q35863367 | Herpes simplex virus-based vectors |
| Q39756417 | Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification |
| Q33468717 | Improved long-term expression from helper virus-free HSV-1 vectors packaged using combinations of mutated HSV-1 proteins that include the UL13 protein kinase and specific components of the VP16 transcriptional complex |
| Q41820330 | Improved spatial learning in aged rats by genetic activation of protein kinase C in small groups of hippocampal neurons |
| Q57020987 | In vivo methods for acute modulation of gene expression in the central nervous system |
| Q40196434 | Isolation of an enhancer from the rat tyrosine hydroxylase promoter that supports long-term, neuronal-specific expression from a neurofilament promoter, in a helper virus-free HSV-1 vector system |
| Q43244057 | Long-term inducible expression in striatal neurons from helper virus-free HSV-1 vectors that contain the tetracycline-inducible promoter system |
| Q43211527 | Long-term transgene expression in mouse neural progenitor cells modified with phiC31 integrase |
| Q42141797 | Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI |
| Q41571273 | Overexpression of either lysine-specific demethylase-1 or CLOCK, but not Co-Rest, improves long-term expression from a modified neurofilament promoter, in a helper virus-free HSV-1 vector system |
| Q26824184 | Parkinson's disease: gene therapies |
| Q36853737 | Subthalamic hGAD65 gene therapy and striatum TH gene transfer in a Parkinson's disease rat model |
| Q24298406 | The assays of activities and function of TH, AADC, and GCH1 and their potential use in ex vivo gene therapy of PD |
| Q39617892 | The vesicular glutamate transporter-1 upstream promoter and first intron each support glutamatergic-specific expression in rat postrhinal cortex |
| Q42052125 | Understanding and prevention of "therapy-" induced dyskinesias |
| Q33908524 | Use of the 2A peptide for generation of multi-transgenic pigs through a single round of nuclear transfer. |
| Q37946113 | Viral vectors for gene delivery to the central nervous system |
Search more.